Gastrointestinal Drugs Market Report

Europe Gastrointestinal Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 19, 2020
  • PAGES：164
  • REPORT CODE：GMM559613
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Gastrointestinal Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gastrointestinal Drugs Market Segmentations:

    By Player:

    • Takeda Pharmaceutical

    • Valeant Pharmaceuticals

    • Allergan

    • Abbott Laboratories

    • AstraZeneca

    • Sanofi

    • Janssen Biotech

    • Boehringer Ingelheim

    • Bayer

    • GlaxoSmithKline

    By Type:

    • Acid Neutralizers

    • Antidiarrheal and Laxatives

    • Antiemetic and Antinauseants

    • Anti-inflammatory Drugs

    • Biologics

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gastrointestinal Drugs Market Size and Growth Rate of Acid Neutralizers from 2014 to 2026

    • 1.3.2 Europe Gastrointestinal Drugs Market Size and Growth Rate of Antidiarrheal and Laxatives from 2014 to 2026

    • 1.3.3 Europe Gastrointestinal Drugs Market Size and Growth Rate of Antiemetic and Antinauseants from 2014 to 2026

    • 1.3.4 Europe Gastrointestinal Drugs Market Size and Growth Rate of Anti-inflammatory Drugs from 2014 to 2026

    • 1.3.5 Europe Gastrointestinal Drugs Market Size and Growth Rate of Biologics from 2014 to 2026

    • 1.3.6 Europe Gastrointestinal Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Europe Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gastrointestinal Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastrointestinal Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Acid Neutralizers

      • 3.4.2 Market Size and Growth Rate of Antidiarrheal and Laxatives

      • 3.4.3 Market Size and Growth Rate of Antiemetic and Antinauseants

      • 3.4.4 Market Size and Growth Rate of Anti-inflammatory Drugs

      • 3.4.5 Market Size and Growth Rate of Biologics

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Gastrointestinal Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastrointestinal Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital Pharmacies for Construction

      • 4.4.2 Market Size and Growth Rate of Retail Pharmacies for Construction

      • 4.4.3 Market Size and Growth Rate of Online Pharmacies for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Gastrointestinal Drugs Production Analysis by Top Regions

    • 5.2 Europe Gastrointestinal Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Gastrointestinal Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gastrointestinal Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gastrointestinal Drugs Landscape Analysis

    • 7.1 Germany Gastrointestinal Drugs Landscape Analysis by Major Types

    • 7.2 Germany Gastrointestinal Drugs Landscape Analysis by Major End-Users

    8. UK Gastrointestinal Drugs Landscape Analysis

    • 8.1 UK Gastrointestinal Drugs Landscape Analysis by Major Types

    • 8.2 UK Gastrointestinal Drugs Landscape Analysis by Major End-Users

    9. France Gastrointestinal Drugs Landscape Analysis

    • 9.1 France Gastrointestinal Drugs Landscape Analysis by Major Types

    • 9.2 France Gastrointestinal Drugs Landscape Analysis by Major End-Users

    10. Italy Gastrointestinal Drugs Landscape Analysis

    • 10.1 Italy Gastrointestinal Drugs Landscape Analysis by Major Types

    • 10.2 Italy Gastrointestinal Drugs Landscape Analysis by Major End-Users

    11. Spain Gastrointestinal Drugs Landscape Analysis

    • 11.1 Spain Gastrointestinal Drugs Landscape Analysis by Major Types

    • 11.2 Spain Gastrointestinal Drugs Landscape Analysis by Major End-Users

    12. Poland Gastrointestinal Drugs Landscape Analysis

    • 12.1 Poland Gastrointestinal Drugs Landscape Analysis by Major Types

    • 12.2 Poland Gastrointestinal Drugs Landscape Analysis by Major End-Users

    13. Russia Gastrointestinal Drugs Landscape Analysis

    • 13.1 Russia Gastrointestinal Drugs Landscape Analysis by Major Types

    • 13.2 Russia Gastrointestinal Drugs Landscape Analysis by Major End-Users

    14. Switzerland Gastrointestinal Drugs Landscape Analysis

    • 14.1 Switzerland Gastrointestinal Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Gastrointestinal Drugs Landscape Analysis by Major End-Users

    15. Turkey Gastrointestinal Drugs Landscape Analysis

    • 15.1 Turkey Gastrointestinal Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Gastrointestinal Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Gastrointestinal Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gastrointestinal Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Gastrointestinal Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Takeda Pharmaceutical

      • 19.1.1 Takeda Pharmaceutical Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Valeant Pharmaceuticals

      • 19.2.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Allergan

      • 19.3.1 Allergan Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Abbott Laboratories

      • 19.4.1 Abbott Laboratories Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 AstraZeneca

      • 19.5.1 AstraZeneca Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Sanofi

      • 19.6.1 Sanofi Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Janssen Biotech

      • 19.7.1 Janssen Biotech Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Boehringer Ingelheim

      • 19.8.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Bayer

      • 19.9.1 Bayer Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 GlaxoSmithKline

      • 19.10.1 GlaxoSmithKline Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 115 Figures and 201 Tables)

    • Figure Product Picture

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Acid Neutralizers Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Antidiarrheal and Laxatives Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Antiemetic and Antinauseants Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Anti-inflammatory Drugs Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Biologics Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Germany Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gastrointestinal Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gastrointestinal Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Acid Neutralizers Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Antidiarrheal and Laxatives Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Antiemetic and Antinauseants Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Anti-inflammatory Drugs Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Biologics Market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Table Europe Gastrointestinal Drugs Production by Major Regions

    • Table Europe Gastrointestinal Drugs Production Share by Major Regions

    • Figure Europe Gastrointestinal Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Gastrointestinal Drugs Consumption by Major Regions

    • Table Europe Gastrointestinal Drugs Consumption Share by Major Regions

    • Table Germany Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table UK Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table France Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Takeda Pharmaceutical Profiles

    • Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Takeda Pharmaceutical Product benchmarking

    • Table Takeda Pharmaceutical Strategic initiatives

    • Table Takeda Pharmaceutical SWOT analysis

    • Table Valeant Pharmaceuticals Profiles

    • Table Valeant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Pharmaceuticals Product benchmarking

    • Table Valeant Pharmaceuticals Strategic initiatives

    • Table Valeant Pharmaceuticals SWOT analysis

    • Table Allergan Profiles

    • Table Allergan Production, Value, Price, Gross Margin 2014-2019

    • Table Allergan Product benchmarking

    • Table Allergan Strategic initiatives

    • Table Allergan SWOT analysis

    • Table Abbott Laboratories Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Abbott Laboratories Product benchmarking

    • Table Abbott Laboratories Strategic initiatives

    • Table Abbott Laboratories SWOT analysis

    • Table AstraZeneca Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table AstraZeneca Product benchmarking

    • Table AstraZeneca Strategic initiatives

    • Table AstraZeneca SWOT analysis

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Janssen Biotech Profiles

    • Table Janssen Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Janssen Biotech Product benchmarking

    • Table Janssen Biotech Strategic initiatives

    • Table Janssen Biotech SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Bayer Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Product benchmarking

    • Table Bayer Strategic initiatives

    • Table Bayer SWOT analysis

    • Table GlaxoSmithKline Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table GlaxoSmithKline Product benchmarking

    • Table GlaxoSmithKline Strategic initiatives

    • Table GlaxoSmithKline SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US